Skip Nav Destination
The natural history and treatment outcome of blast phase BCR-ABL− myeloproliferative neoplasms
Free
A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome
Free
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies
Free
Detection of T lymphocytes with a second-site mutation in skin lesions of atypical X-linked severe combined immunodeficiency mimicking Omenn syndrome
Free
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication
Free
mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia
Free
Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia
Free
Expansion of donor-derived hematopoietic stem cells with PIGA mutation associated with late graft failure after allogeneic stem cell transplantation
Free
Issue Archive
September 1 2008
In this Issue
Table of Contents
INSIDE BLOOD
ASH 50TH ANNIVERSARY REVIEW
BLOOD WORK
PLENARY PAPERS
Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia Free
Jason E. Farrar,Michelle Nater,Emi Caywood,Michael A. McDevitt,Jeanne Kowalski,Clifford M. Takemoto,C. Conover Talbot, Jr,Paul Meltzer,Diane Esposito,Alan H. Beggs,Hal E. Schneider,Agnieszka Grabowska,Sarah E. Ball,Edyta Niewiadomska,Colin A. Sieff,Adrianna Vlachos,Eva Atsidaftos,Steven R. Ellis,Jeffrey M. Lipton,Hanna T. Gazda,Robert J. Arceci
REVIEW ARTICLES
European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas Free
Nancy J. Senff,Evert M. Noordijk,Youn H. Kim,Martine Bagot,Emilio Berti,Lorenzo Cerroni,Reinhard Dummer,Madeleine Duvic,Richard T. Hoppe,Nicola Pimpinelli,Steven T. Rosen,Maarten H. Vermeer,Sean Whittaker,Rein Willemze
CHEMOKINES, CYTOKINES, AND INTERLEUKINS
Increased serum levels of the chemokine CXCL13 and up-regulation of its gene expression are distinctive features of HCV-related cryoglobulinemia and correlate with active cutaneous vasculitis Free
Domenico Sansonno,Felicia Anna Tucci,Laura Troiani,Gianfranco Lauletta,Michele Montrone,Vincenza Conteduca,Loredana Sansonno,Franco Dammacco
CLINICAL TRIALS AND OBSERVATIONS
The natural history and treatment outcome of blast phase BCR-ABL− myeloproliferative neoplasms
Free
Clinical Trials & Observations
Constantine S. Tam,Roberto M. Nussenzveig,Uday Popat,Carlos E. Bueso-Ramos,Deborah A. Thomas,Jorge A. Cortes,Richard E. Champlin,Stefan E. Ciurea,Taghi Manshouri,Sherry M. Pierce,Hagop M. Kantarjian,Srdan Verstovsek
A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome
Free
Clinical Trials & Observations
Stefan Faderl,Farhad Ravandi,Xuelin Huang,Guillermo Garcia-Manero,Alessandra Ferrajoli,Zeev Estrov,Gautam Borthakur,Srdan Verstovsek,Deborah A. Thomas,Monica Kwari,Hagop M. Kantarjian
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies
Free
Clinical Trials & Observations
Wendy Stock,Mei La,Ben Sanford,Clara D. Bloomfield,James W. Vardiman,Paul Gaynon,Richard A. Larson,James Nachman
GENE THERAPY
HEMATOPOIESIS AND STEM CELLS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Role of VEGF-D and VEGFR-3 in developmental lymphangiogenesis, a chemicogenetic study in Xenopus tadpoles Free
Annelii Ny,Marta Koch,Wouter Vandevelde,Martin Schneider,Christian Fischer,Antonio Diez-Juan,Elke Neven,Ilse Geudens,Sunit Maity,Lieve Moons,Stéphane Plaisance,Diether Lambrechts,Peter Carmeliet,Mieke Dewerchin
IMMUNOBIOLOGY
STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cells Free
Peter A. Cohen,Gary K. Koski,Brian J. Czerniecki,Kevin D. Bunting,Xin-Yuan Fu,Zhengqi Wang,Wen-Jun Zhang,Charles S. Carter,Mohamed Awad,Christopher A. Distel,Hassan Nagem,Christopher C. Paustian,Terrence D. Johnson,John F. Tisdale,Suyu Shu
Detection of T lymphocytes with a second-site mutation in skin lesions of atypical X-linked severe combined immunodeficiency mimicking Omenn syndrome
Free
Brief Report
Taizo Wada,Masahiro Yasui,Tomoko Toma,Yuko Nakayama,Mika Nishida,Masaki Shimizu,Michiko Okajima,Yoshihito Kasahara,Shoichi Koizumi,Masami Inoue,Keisei Kawa,Akihiro Yachie
NEOPLASIA
Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia Free
Laura Z. Rassenti,Sonia Jain,Michael J. Keating,William G. Wierda,Michael R. Grever,John C. Byrd,Neil E. Kay,Jennifer R. Brown,John G. Gribben,Donna S. Neuberg,Feng He,Andrew W. Greaves,Kanti R. Rai,Thomas J. Kipps
Biologic and genetic characterization of the novel amyloidogenic lambda light chain–secreting human cell lines, ALMC-1 and ALMC-2 Free
Bonnie K. Arendt,Marina Ramirez-Alvarado,Laura A. Sikkink,Jonathan J. Keats,Gregory J. Ahmann,Angela Dispenzieri,Rafael Fonseca,Rhett P. Ketterling,Ryan A. Knudson,Erin M. Mulvihill,Renee C. Tschumper,Xiaosheng Wu,Steven R. Zeldenrust,Diane F. Jelinek
Sμ mutation patterns suggest different progression pathways in follicular lymphoma: early direct or late from FL progenitor cells Free
Philippe Ruminy,Fabrice Jardin,Jean-Michel Picquenot,Françoise Parmentier,Nathalie Contentin,Gérard Buchonnet,Sandrine Tison,Vinciane Rainville,Hervé Tilly,Christian Bastard
Primary cystic lung light chain deposition disease: a clinicopathologic entity derived from unmutated B cells with a stereotyped IGHV4-34/IGKV1 receptor Free
Magali Colombat,Hervé Mal,Christiane Copie-Bergman,Jacques Diebold,Diane Damotte,Patrice Callard,Michel Fournier,Jean-Pierre Farcet,Marc Stern,Marie-Hélène Delfau-Larue
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication
Free
Brief Report
Susan P. Whitman,Björn Hackanson,Sandya Liyanarachchi,Shujun Liu,Laura J. Rush,Kati Maharry,Dean Margeson,Ramana Davuluri,Jing Wen,Tatiana Witte,Li Yu,Chunhui Liu,Clara D. Bloomfield,Guido Marcucci,Christoph Plass,Michael A. Caligiuri
mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia
Free
Brief Report
David T. Teachey,Cecilia Sheen,Junior Hall,Theresa Ryan,Valerie I. Brown,Jonathan Fish,Gregor S. D. Reid,Alix E. Seif,Robin Norris,Yueh J. Chang,Martin Carroll,Stephan A. Grupp
Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia
Free
Brief Report
Stéphanie Dulucq,Stéphane Bouchet,Béatrice Turcq,Eric Lippert,Gabriel Etienne,Josy Reiffers,Mathieu Molimard,Maja Krajinovic,François-Xavier Mahon
PHAGOCYTES
RED CELLS
A novel loss-of-function mutation in the proton-coupled folate transporter from a patient with hereditary folate malabsorption reveals that Arg 113 is crucial for function Free
Inbal Lasry,Bluma Berman,Rachel Straussberg,Yael Sofer,Hanna Bessler,Mohamad Sharkia,Fabian Glaser,Gerrit Jansen,Stavit Drori,Yehuda G. Assaraf
TRANSFUSION MEDICINE
Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population Free
Sumithira Vasu,Susan F. Leitman,John F. Tisdale,Matthew M. Hsieh,Richard W. Childs,A. John Barrett,Daniel H. Fowler,Michael R. Bishop,Elizabeth M. Kang,Harry L. Malech,Cynthia E. Dunbar,Hanh M. Khuu,Robert Wesley,Yu Y. Yau,Charles D. Bolan
TRANSPLANTATION
Mannose-binding lectin status is associated with risk of major infection following myeloablative sibling allogeneic hematopoietic stem cell transplantation Free
Charles G. Mullighan,Susan L. Heatley,Silke Danner,Melinda M. Dean,Kathleen Doherty,Uwe Hahn,Kenneth F. Bradstock,Robyn Minchinton,Anthony P. Schwarer,Jeff Szer,Peter G. Bardy
Angiopoietin-2 predicts disease-free survival after allogeneic stem cell transplantation in patients with high-risk myeloid malignancies Free
Philipp Kümpers,Christian Koenecke,Hartmut Hecker,Julian Hellpap,Rüdiger Horn,Willem Verhagen,Stefanie Buchholz,Bernd Hertenstein,Jürgen Krauter,Matthias Eder,Sascha David,Gudrun Göhring,Hermann Haller,Arnold Ganser
Expansion of donor-derived hematopoietic stem cells with PIGA mutation associated with late graft failure after allogeneic stem cell transplantation
Free
Brief Report
Kanako Mochizuki,Chiharu Sugimori,Zhirong Qi,Xuzhang Lu,Akiyoshi Takami,Ken Ishiyama,Yukio Kondo,Hirohito Yamazaki,Hirokazu Okumura,Shinji Nakao
CORRESPONDENCE
ERRATUM
-
Cover Image
Cover Image
A homology model of the ADAMTS13 metalloprotease (magenta) and disintegrin-like domains (cyan) is shown in the center, with the active site Zn2+ ion (green) and the three structural Ca2+ ions (grey) shown as spheres. ADAMTS13 is flanked by the native folded VWF A2 domain (top left) in which the target Tyr1605-Met1606 (red) bond is buried in the fourth strand of a beta sheet, and by a partially unfolded VWF A2 domain (bottom left) in which this bond is exposed to ADAMTS13. See the related article by Gao et al beginning on page 1713.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals